Licochalcone B alleviates atherosclerosis by inhibiting endothelial inflammation via targeting the KEAP1/NRF2/NF-κB signalling pathway
- 22 May 2026
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 157, 158333
Abstract
No abstract availableKeywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province (2024A1515140121)
- Basic and Applied Basic Research Foundation of Guangdong Province (2026A1515010440)
- Basic and Applied Basic Research Foundation of Guangdong Province (2025A1515010149)
- National Natural Science Foundation of China (82571787)
- National Natural Science Foundation of China (82071576)
- National Natural Science Foundation of China (82001466)
This publication has 45 references indexed in Scilit:
- Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative as a human topoisomerase I inhibitor with efficacy against bone cancer cells and colon adenocarcinomaEuropean Journal of Medicinal Chemistry, 2023
- Licochalcone B attenuates neuronal injury through anti-oxidant effect and enhancement of Nrf2 pathway in MCAO rat model of strokeInternational Immunopharmacology, 2021
- Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stressJournal of Advanced Research, 2021
- Senolytic agent Quercetin ameliorates intervertebral disc degeneration via the Nrf2/NF-κB axisOsteoarthritis and Cartilage, 2021
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019JACC, 2020
- Janus kinase 2 inhibition by Licochalcone B suppresses esophageal squamous cell carcinoma growthPhytotherapy Research, 2020
- Effect of vildagliptin and pravastatin combination on cholesterol efflux in adipocytesIUBMB Life, 2016
- The antiviral and antimicrobial activities of licorice, a widely-used Chinese herbActa Pharmaceutica Sinica B, 2015
- Pathogenesis of AtherosclerosisJACC, 2006
- Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stressCardiovascular Research, 2004